American Journal of Cardiology
Volume 104, Issue 10 , Pages 1330-1335 , 15 November 2009

Comparison of Site-Reported and Core Laboratory-Reported Creatine Kinase-MB Values in Non–ST-Segment Elevation Acute Coronary Syndrome (from the International Trial SYNERGY)

  • Jason P. Linefsky, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Min Lin, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Karen S. Pieper, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Craig J. Reist, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Lisa G. Berdan, PA-C

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Elliott M. Antman, MD

      Affiliations

    • Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • Shaun G. Goodman, MD

      Affiliations

    • St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • John K. French, MB, ChB, PhD

      Affiliations

    • University of New South Wales, Sydney, New South Wales, Australia
    • ,
  • Sema Guneri, MD

      Affiliations

    • Dokuz Eylul Universitesi, Smyrna, Turkey
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • L. Kristin Newby, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • James J. Ferguson, MD

      Affiliations

    • The Medicines Company, Parsippany, New Jersey
    • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Kenneth W. Mahaffey, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: (919) 668-8845; fax: (919) 688-7059

Received 12 March 2009 ,Revised 19 June 2009 ,Accepted 19 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The SYNERGY trial was funded by Sanofi-Aventis, Bridgewater, New Jersey.

PII: S0002-9149(09)01318-6

doi: 10.1016/j.amjcard.2009.06.056

American Journal of Cardiology
Volume 104, Issue 10 , Pages 1330-1335 , 15 November 2009

Article Tools

* Image Usage & Resolution